ABTC Protocol Status

As of April 12, 2018 at 2:10 P.M.

Protocol Number Protocol Title Newly or Recurrent Current Phase Protocol Arm/Group Slots Available Slots on Hold Total number of patients enrolled to date Current Status Wait List Est. Next Cohort Start Date
1202 MK-1775 Newly I Combination Dose Cohort 0

1(UP)

Arm 1: 15

Arm 2: 24

Combination Dose: 17

TEMP CLOSED

NA NA
1202 MK-1775 Recurrent I Intratumoral Drug Distribution 0 0

12

(+1replaced)

CLOSED NA NA
1301 MLN-0128 Recurrent 0

   Part 2   

Groups A and B

2 0

Part 1-Cohort A: 11

Part 1: Cohort B: 5

(+1replaced)

Part 2: 18 (+2replaced)

 OPEN

NA

NA
1302 LAPATINIB Recurrent 0 Group A 5 1(HF) 14

OPEN

NA NA
1403 Il-7 Newly NA

Group A

(Dex≤0.75mg/day)

30 0 0

CLOSED 

NA Early 2018. Amendment underway
1403 Il-7 Newly NA

Group B

(Dex<0.75mg/day)

20 0 0 CLOSED NA Early 2018. Amendment underway
1501 Checkpoint Inhibitors Recurrent I

PartA LAG-3 Mono

PartA CD137 Mono

PartB LAG-3 Combo

0 1(WF)

30

(+2replaced)

TEMP CLOSED

1(DF)

NA
1601

BAL101553

Newly I Dose Escalation 3 0 2 TEMP ON HOLD NA NA
1602 PT2385 Recurrent II Stage 1 0

0

24 (+2replaced)

CLOSED

NA NA